Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
Background Cardiac allograft vasculopathy (CAV) limits survival after heart transplantation, and the effect of different immunosuppressive regimens on CAV is not fully understood. The randomized SCHEDULE trial (Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | anglais |
| Publié: |
2018
|
| Accès en ligne: | https://doi.org/10.1161/circheartfailure.117.004050 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|